Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Hosted content
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Hosted content
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 64, Issue 6
Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Hepatology
Original article
Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study
Online download statistics by month:
Online download statistics by month: July 2014 to March 2024
Abstract
Full
Pdf
Jul 2014
170
3
13
Aug 2014
643
107
178
Sep 2014
253
74
89
Oct 2014
105
42
52
Nov 2014
124
36
39
Dec 2014
115
40
31
Jan 2015
85
32
28
Feb 2015
85
36
48
Mar 2015
71
30
32
Apr 2015
67
24
30
May 2015
1147
60
161
Jun 2015
582
29
53
Jul 2015
283
35
75
Aug 2015
228
29
52
Sep 2015
138
30
40
Oct 2015
94
4
15
Nov 2015
136
10
12
Dec 2015
137
20
22
Jan 2016
147
19
29
Feb 2016
123
11
28
Mar 2016
54
25
21
Apr 2016
83
7
9
May 2016
96
82
17
Jun 2016
110
23
20
Jul 2016
58
25
19
Aug 2016
48
13
13
Sep 2016
106
11
10
Oct 2016
67
4
4
Nov 2016
62
1
2
Dec 2016
72
1
4
Jan 2017
66
2
4
Feb 2017
76
7
4
Mar 2017
73
4
4
Apr 2017
57
8
7
May 2017
66
7
6
Jun 2017
60
2
2
Jul 2017
125
4
2
Aug 2017
152
4
3
Sep 2017
127
5
4
Oct 2017
97
4
2
Nov 2017
117
9
7
Dec 2017
106
5
4
Jan 2018
111
3
7
Feb 2018
76
4
3
Mar 2018
202
6
2
Apr 2018
73
6
2
May 2018
105
9
6
Jun 2018
90
1
1
Jul 2018
147
4
0
Aug 2018
239
3
2
Sep 2018
129
1
1
Oct 2018
215
2
3
Nov 2018
192
1
1
Dec 2018
208
0
0
Jan 2019
177
4
2
Feb 2019
128
14
14
Mar 2019
109
7
4
Apr 2019
94
4
4
May 2019
88
5
4
Jun 2019
64
2
3
Jul 2019
32
2
0
Aug 2019
97
1
1
Sep 2019
37
3
0
Oct 2019
69
2
1
Nov 2019
41
6
0
Dec 2019
104
0
0
Jan 2020
16
0
0
Feb 2020
43
2
1
Mar 2020
83
1
1
Apr 2020
48
1
0
May 2020
53
3
3
Jun 2020
44
0
0
Jul 2020
23
0
0
Aug 2020
18
1
0
Sep 2020
83
5
3
Oct 2020
38
0
0
Nov 2020
31
0
2
Dec 2020
41
0
0
Jan 2021
48
2
0
Feb 2021
41
2
0
Mar 2021
33
1
1
Apr 2021
70
4
1
May 2021
17
2
1
Jun 2021
2
2
0
Jul 2021
3
3
0
Sep 2021
4
2
1
Oct 2021
31
2
3
Nov 2021
41
3
0
Dec 2021
27
4
0
Jan 2022
104
0
1
Feb 2022
58
6
1
Mar 2022
132
2
2
Apr 2022
68
5
0
May 2022
73
7
4
Jun 2022
78
4
3
Jul 2022
49
7
0
Aug 2022
54
2
1
Sep 2022
67
6
0
Oct 2022
47
2
1
Nov 2022
56
5
1
Dec 2022
57
4
1
Jan 2023
61
5
2
Feb 2023
71
2
0
Mar 2023
47
5
1
Apr 2023
13
4
0
May 2023
69
7
0
Jun 2023
45
3
1
Jul 2023
23
3
0
Aug 2023
40
2
0
Sep 2023
35
4
1
Oct 2023
61
1
0
Nov 2023
64
7
1
Dec 2023
64
6
2
Jan 2024
42
2
2
Feb 2024
53
1
2
Mar 2024
32
9
2
Total
11839
1165
1302
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF